Back to top
more

TESARO, Inc. (TSRO)

(Delayed Data from NSDQ)

$74.96 USD

74.96
NA

0.00 (0.00%)

Updated Jan 18, 2019 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[TSRO]

Reports for Purchase

Showing records 1 - 20 ( 141 total )

Industry: Medical - Drugs

Record: 1

01/23/2019

Company Report

Pages: 6

Termination of Coverage

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 2

01/22/2019

Daily Note

Pages: 4

We are dropping coverage of Tesaro due to completion of its acquisition by GlaxoSmithKline Not Covered.

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 3

01/14/2019

Industry Report

Pages: 9

HEALTHCARE - The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 4

01/06/2019

Industry Report

Pages: 10

The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 5

12/24/2018

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Drugs

Record: 6

12/07/2018

Company Report

Pages: 6

TESARO Proposed Acquisition by GlaxoSmithKline; Rating Change to Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 7

12/04/2018

Daily Note

Pages: 7

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 8

12/04/2018

Company Report

Pages: 6

Downgrading to Neutral, GSK Lassos TSRO for $75/Share

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 9

12/04/2018

Company Report

Pages: 2

GSK Went Christmas Shopping; Changing Recommendation to Hold

Provider: G.RESEARCH, LLC

Analyst: HE J

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 10

12/03/2018

Daily Note

Pages: 3

GSK Proposes Acquisition of TESARO for $75 Per Share Cash

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 11

11/22/2018

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Drugs

Record: 12

11/19/2018

Company Report

Pages: 2

Tesaro was speculated to explore a sale

Provider: G.RESEARCH, LLC

Analyst: HE J

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 13

11/14/2018

Industry Report

Pages: 13

SITC 2018 Roundup for Covered Companies

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 14

11/13/2018

Company Report

Pages: 12

SITC Presentations Showcase TSRO?s I/O Potential and Upcoming Data

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 15

11/13/2018

Company Report

Pages: 5

Program Updates Presented at Investor Meeting; Interim Clinical Insights at SITC

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 16

11/02/2018

Company Report

Pages: 7

Q3 Financials; Zejula Growth and Burn Rate Improves, but Financing Risk Lingers

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 17

11/02/2018

Company Report

Pages: 5

TESARO 3Q18 Results; Promising Zejula Sales and Pipeline Progress; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 18

10/29/2018

Daily Note

Pages: 3

TESARO Announces Zejula Development Milestones; To Receive $18M From Janssen

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 19

10/28/2018

Industry Report

Pages: 8

HEALTHCARE - The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 20

10/23/2018

Industry Report

Pages: 10

Biotechnology - ESMO 2018 Roundup for Covered Companies

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party
// eof